Associations of baseline characteristics with evolution of eGFR in a referred chronic kidney disease cohort

QJM: An International Journal of Medicine

Volumn 106, Issue 10, 2013, Pages 915-924

  Hoefield, R A ^a   Kalra, P A ^a   Lane, B ^a   O'donoghue, D J ^a   Foley, R N ^b   Middleton, R J ^a  

^a UNIVERSITY OF MANCHESTER   (United Kingdom)

^b UNIVERSITY OF MINNESOTA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ALBUMIN; ANTIANEMIC AGENT; C REACTIVE PROTEIN; CALCIUM PHOSPHATE; CHOLESTEROL; CREATININE; HEMOGLOBIN; HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE INHIBITOR; PARATHYROID HORMONE; POTASSIUM; SODIUM; UREA;

AGED; ARTICLE; CHRONIC KIDNEY DISEASE; CREATININE BLOOD LEVEL; DIABETIC NEPHROPATHY; DIASTOLIC BLOOD PRESSURE; DISEASE ASSOCIATION; FEMALE; FOLLOW UP; GLOMERULUS FILTRATION RATE; HUMAN; KIDNEY BIOPSY; KIDNEY POLYCYSTIC DISEASE; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; PROTEINURIA; RENAL REPLACEMENT THERAPY; SYSTOLIC BLOOD PRESSURE;

AGED; COHORT STUDIES; DISEASE PROGRESSION; FEMALE; GLOMERULAR FILTRATION RATE; HUMANS; MALE; MIDDLE AGED; PROGNOSIS; PROTEINURIA; RENAL INSUFFICIENCY, CHRONIC; RISK FACTORS;

EID: 84884723362     PISSN: 14602725     EISSN: 14602393     Source Type: Journal    
DOI: 10.1093/qjmed/hct115     Document Type: Article

References (29)

1. National Kidney Foundation K/DOQI. Part 4. Definition and classification of stages of chronic kidney disease. Am J Kidney Dis 2002; 39(Suppl. 1):S46-75.
2. National Kidney Foundation. K/DOQI Kidney disease outcome quality initiative. Clinical practice guidelines for chronic kidney disease: evaluation, classification, and stratification. Am J Kidney Dis 2002; 39(Suppl. 1):S1-266.
3. The Scottish intercollegiate guidelines network (SIGN). Guideline No. 103, Diagnosis and Management of Chronic Kidney Disease, Edinburgh, Scotland, June 2008.
4. National Institute for Health and Clinical Excellence. CG73 Chronic Kidney Disease NICE Guideline, www.nice.org.uk/ nicemedia/pdf/CG073FullGuideline.pdf (3 October 2012, date last accessed).
5. Turin TC, Coresh J, Tonelli M, Stevens PE, de Jong PE, Farmer CK, et al. Short-term change in kidney function and risk of end-stage renal disease. Nephrol Dial Transplant 2012; 27:3835-43.
6. Eriksen BO, Ingebretsen OC. The progression of chronic kidney disease: a 10-year population-based study of the effects of gender and age. Kidney Int 2006; 69:375-82.
7. Hunsicker LG, Adler S, Caggiula A, England BK, Greene T, Kusek JW, et al. Predictors of the progression of renal disease in the Modification of Diet in Renal Disease Study. Kidney Int 1997; 51:1908-19.
8. Jones C, Roderick P, Harris S, Rogerson M. Decline in kidney function before and after nephrology referral and the effect on survival in moderate to advanced chronic kidney disease. Nephrol Dial Transplant 2006; 21:2133-43.
9. Levin A, Djurdjev O, Beaulieu M, Er L. Variability and risk factors for kidney disease progression and death following attainment of stage 4 CKD in a referred cohort. Am J Kidney Dis 2008; 52:661-71.
10. Zhang AH, Tam P, LeBlanc D, Zhong H, Chan CT, Bargman JM, et al. Natural history of CKD stage 4 and 5 patients following referral to renal management clinic. Int Urol Nephrol 2009; 41:977-82.
11. Kidney Disease: Improving Global Outcomes (KDIGO) CKD Work Group. KDIGO 2012 Clinical Practice Guideline for the Evaluation and Management of Chronic Kidney Disease. Kidney Int 2013; 3(Suppl. 3):1-150.
12. Swets JA. The relative operating characteristic in psychology: a technique for isolating effects of response bias finds wide use in the study of perception and cognition. Science 1973; 182:990-1000.
13. Levey AS, Bosch JP, Lewis JB, Greene T, Rogers N, Roth D. A more accurate method to estimate glomerular filtration rate from serum creatinine: a new prediction equation. Modification of Diet in Renal Disease Study Group. Ann Intern Med 1999; 130:461-70.
14. Levey AS, Stevens LA, Schmid CH, Zhang YL, Castro AF III, Feldman HI, et al. A new equation to estimate glomerular filtration rate. Ann Intern Med 2009; 150:604-12.
15. Taskapan H, Tam P, Au V, Chow S, Fung J, Nagai G, et al. Improvement in eGFR in patients with chronic kidney disease attending a nephrology clinic. Int Urol Nephrol 2008; 40:841-8.
16. Yoshida T, Takei T, Shirota S, Tsukada M, Sugiura H, Itabashi M, et al. Risk factors for progression in patients with early-stage chronic kidney disease in the Japanese population. Intern Med 2008; 47:1859-64.
17. Ansell D, Feehally J, Fogarty D, Inward C, Tomson CRV, Warwick G, et al. UK Renal Registry 12th Annual Report (December 2009). Bristol, UK: UK Renal Registry, 2010.
18. Chuahirun T, Wesson DE. Cigarette smoking predicts faster progression of type 2 established diabetic nephropathy despite ACE inhibition. Am J Kidney Dis 2002; 39:376-82.
19. Chuahirun T, Khanna A, Kimball K, Wesson DE. Cigarette smoking and increased urine albumin excretion are interrelated predictors of nephropathy progression in type 2 diabetes. Am J Kidney Dis 2003; 41:13-21.
20. Orth SR, Ritz E, Schrier RW. The renal risks of smoking. Kidney Int 1997; 51:1669-77.
21. Baigent C, Landray MJ, Reith C, Emberson J, Wheeler DC, Tomson C, et al. The effects of lowering LDL cholesterol with simvastatin plus ezetimibe in patients with chronic kidney disease (Study of Heart and Renal Protection): a randomised placebo-controlled trial. Lancet 2011; 377:2181-92.
22. Johnson ES, Thorp ML, Platt RW, Smith DH. Predicting the risk of dialysis and transplant among patients with CKD: a retrospective cohort study. Am J Kidney Dis 2008; 52:653-60.
23. Keane WF, Zhang Z, Lyle PA, Cooper ME, De ZD, Grunfeld JP, et al. Risk scores for predicting outcomes in patients with type 2 diabetes and nephropathy: the RENAAL study. Clin J Am Soc Nephrol 2006; 1:761-7.
24. Taal MW, Brenner BM. Predicting initiation and progression of chronic kidney disease: developing renal risk scores. Kidney Int 2006; 70:1694-705.
25. Taal MW, Brenner BM. Renal risk scores: progress and prospects. Kidney Int 2008; 73:1216-9.
26. Thorp ML, Eastman L, Smith DH, Johnson ES. Managing the burden of chronic kidney disease. Dis Manag 2006; 9:115-21.
27. Peralta CA, Shlipak MG, Judd S, Cushman M, McClellan W, Zakai NA, et al. Detection of chronic kidney disease with creatinine, cystatin C, and urine albumin-to-creatinine ratio and association with progression to end-stage renal disease and mortality. JAMA 2011; 305:1545-52.
28. Tangri N, Stevens LA, Griffith J, Tighiouart H, Djurdjev O, Naimark D, et al. A predictive model for progression of chronic kidney disease to kidney failure. JAMA 2011; 305:1553-9.
29. O'Seaghdha CM, Lyass A, Massaro JM, Meigs JB, Coresh J, D'Agostino RB Sr et al. A risk score for chronic kidney disease in the general population. Am J Med 2012; 125:270-7.